Global Blood Therapeutics Is Said to Draw Takeover Interest

 Global Blood Therapeutics Inc., which makes a drug for sickle cell disease, is attracting takeover interest, according to people familiar with the matter.

Some large pharmaceutical companies are studying a potential deal, the people said, asking not to be identified because the information is private. The company is working with advisers to evaluate the potential interest, they said. There’s no certainty it will lead to a transaction, the people added.

https://news.bloomberglaw.com/mergers-and-acquisitions/global-blood-therapeutics-is-said-to-draw-takeover-interest